COVID-19 plagues an overtaxed opioid addiction treatment system.
Articles on Naloxone
Displaying 21 - 40 of 43 articles
A new report counts the social costs of pharmaceutical opioid misuse and illegal opioid use in Australia for 2015/2016. The numbers are fairly grim.
Pharmacists are well positioned to provide communities with a lifesaving drug.
Treatments for opioid dependence, such as methadone and buprenorphine, are effective. But some people who stand to benefit are missing out.
Opioid overdoses killed 47,000 Americans in 2017 — more than gun violence. Many fewer would have died if they’d been treated with the life-saving drug naloxone, also called Narcan.
Considered in historical context, Purdue’s plan to peddle opioid addiction medicines to vulnerable people is not so surprising. Gilded-Age pharmaceutical companies used similar strategies.
The toll of the opioid epidemic is often derived from toxicology reports. These rely on drug tests. A medical historian explains these tests and how they fall short of capturing why people are dying.
Naloxone programmes have sprung up in the UK and elsewhere, but drug death rates keep climbing.
There are proven ways to reduce drug deaths. Unfortunately, the UK government is not implementing them.
One study argues that naloxone increases opioid use because it protects against death from overdose. But a closer analysis shows Narcan is the number one public health tool to fight the overdose epidemic.
Opioids kill 100 people each day in the US, more than vehicular accidents. Those addicted are often left without treatment. An addiction researcher offers six steps to address the epidemic.
Catastrophic increases in opioid overdose deaths across Canada require a broad response – tackling housing, food and income insecurity as well as the contaminated drug supply.
Opioids kill an average of eight people every day in Canada. The federal government must officially declare this a ‘public welfare emergency’ and invest the funds critical to a humane response.
The number of people dying from opioid overdose continues to rise, in part because of cheap street drugs. Yet the price of a drug used to treat addiction is out of reach for many.
Carfentanil is an ultra-potent synthetic opioid. Its only legitimate use is in veterinary practice for large animals such as elephants, but it sneaks into heroin shipments to increase its potency.
Opiates have emerged as a significant threat to public health in the UK.
Naloxone is used as an “antidote” for opioid overdose which includes heroin, and opioid pain medicines such as morphine, fentanyl and codeine.
It is thought that in 2002 fentanyl, or a drug based on fentanyl, was used by Russian special forces to disable Chechen rebels after a four day stand off in the Dubrovka theatre in Moscow.
The Senate passed a bill July 13 to address the opioid epidemic. Georgia recently passed a bill that would limit rather than expand the number of treatment centers. Could others follow suit?
Have you ever wondered how the small white ibuprofen pill turns off your headache? Or how a regular antidepressant keeps your brain chemistry in balance?
Top contributors
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Professor of Emergency Medicine, UMass Chan Medical School
-
Professor and Director, National Drug Research Institute, Curtin University
-
Honorary Fellow, Department of Health Sciences, University of York
-
Professor of Intellectual Property, University of California College of the Law, San Francisco
-
University of California, San Francisco
-
Doctoral Candidate, Medical History, Vanderbilt University
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor of Emergency Medicine and Community Health Sciences, Boston University
-
Professor in Criminology, Loughborough University
-
Professor, National Drug Research Institute, Curtin University and Burnet Institute, Burnet Institute
-
Emeritus Consultant, St Vincent's Hospital, Darlinghurst
-
Senior lecturer, Australian National University
-
Professor of Pharmacology, University of Sydney
-
Postdoctoral Fellow, University of British Columbia